myriad.com - Myriad Genetics | Breakthrough Innovations in Molecular Diagnostics

myriad.com Myriad Genetics | Breakthrough Innovations in Molecular Diagnostics
Member Since: 0000-00-00 00:00:00

Myriad Genetics is a leading molecular diagnostic company dedicated to saving and improving lives by discovering and delivering tests across major diseases.


myriad.com Reviews and Rating

Average Rating: 4 / 5
Total Ratings: 1
4/5

Rate and Review myriad.com

Check  myriad.com  Stats

Daily Unique PVs Total PVs Unique In Total In Unique Out Total Out
Average 0.0 0.0 0.0 0.0 0.2 0.2
Today 0 0 0 0 0 0
Yesterday 0 0 0 0 0 0
April 19 0 0 0 0 0 0
April 18 0 0 0 0 1 1
April 17 0 0 0 0 1 1
April 16 0 0 0 0 0 0
April 15 0 0 0 0 0 0
April 14 0 0 0 0 0 0
April 13 0 0 0 0 0 0
April 12 0 0 0 0 0 0
Highest 0 0 0 0 3 8
Weekly Unique PVs Total PVs Unique In Total In Unique Out Total Out
Average 0.0 0.0 0.0 0.0 0.8 0.8
This Week 0 0 0 0 2 2
Last Week 0 0 0 0 0 0
Week 14 0 0 0 0 1 1
Week 13 0 0 0 0 0 0
Week 12 0 0 0 0 0 0
Week 11 0 0 0 0 1 1
Week 10 0 0 0 0 0 0
Week 09 0 0 0 0 0 0
Week 08 0 0 0 0 2 2
Week 07 0 0 0 0 2 2
Highest 0 0 0 0 8 10
Monthly Unique PVs Total PVs Unique In Total In Unique Out Total Out
Average 0.0 0.0 0.0 0.0 3.8 3.8
This Month 0 0 0 0 3 3
Last Month 0 0 0 0 1 1
February 18 0 0 0 0 5 5
January 18 0 0 0 0 6 6
December 17 0 0 0 0 3 3
November 17 0 0 0 0 2 2
October 17 0 0 0 0 4 4
September 17 0 0 0 0 4 4
August 17 0 0 0 0 8 8
July 17 0 0 0 0 2 2
Highest 0 0 0 0 18 19
Unique PVs Total PVs Unique In Total In Unique Out Total Out
Overall 0 0 0 0 176 183

myriad.com Recent News

  • Hereditary Colon Cancer
    Thursday 1st of March 2018 03:25:07 PM
    In hereditary colon cancer, knowledge is power!  During the month of March, Myriad Genetics is demonstrating a strong commitment to preventing hereditary colon cancer as part of National Colorectal Cancer Awareness Month.  Colon cancer is third...
  • BRACAnalysis CDx Approved by FDA for Patients with HER2- Metastatic Breast Cancer
    Tuesday 23rd of January 2018 10:58:51 AM
    The U.S. Food and Drug Administration (FDA) has approved BRACAnalysis CDx® for use as a companion diagnostic to identify patients with HER2- metastatic breast cancer who are candidates for treatment with AstraZeneca’s PARP inhibitor, Lynparza®(...
  • Winter Depression is a Serious Health Issue for Many People
    Wednesday 17th of January 2018 02:34:24 PM
    It is estimated that 19 million people suffer from “year round” depression. If every American with depression lived in one state it would be the country’s fifth largest state. For many of these people, their depression will get worse in the win...
  • Andrea’s story: Cancer prevention can begin with knowing your family history
    Tuesday 10th of October 2017 07:03:22 AM
    Shortly after I was born, my father was diagnosed with Hodgkin’s lymphoma and he passed away when he was just 29 years old.  Losing my dad when I was so young is what ultimately led me to becoming a cancer genetic counselor focusing on cancer prev...
  • Myriad’s Commitment to Breast Cancer
    Sunday 1st of October 2017 07:31:31 AM
    At Myriad, we are committed to defeating breast cancer and we know that decisions matter when it comes to breast cancer. We have several genetic tests that can help women with breast cancer, but can also help others with preventing breast cancer. Cur...